Literature DB >> 29172001

Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.

Ramasamy Thangavel1,2, Sachin M Bhagavan1, Swathi Beladakere Ramaswamy1, Spurthi Surpur1, Raghav Govindarajan1, Duraisamy Kempuraj1,2, Smita Zaheer1, Sudhanshu Raikwar1, Mohammad E Ahmed1, Govindhasamy Pushpavathi Selvakumar1,2, Shankar S Iyer1, Asgar Zaheer1,2.   

Abstract

Apolipoprotein E4 (ApoE4) is a major genetic risk factor for Alzheimer's disease (AD). The E4 allele of ApoE plays a crucial role in the inflammatory and neurodegenerative processes associated with AD. This is evident from the multiple effects of the ApoE isoforms in amyloid-β (Aβ) aggregation. Glia maturation factor (GMF) is a brain-specific neuroinflammatory protein that we have previously demonstrated to be significantly upregulated in various regions of AD brains compared to non-AD control brains and that it induces neurodegeneration. We have previously reported that GMF is predominantly expressed in the reactive astrocytes surrounding amyloid plaques (APs) in AD brain. In the present study, using immunohistochemical and dual immunofluorescence staining, we show the expression and colocalization of GMF and ApoE4 in AD brains. Our results show that ApoE4 is present within the APs of AD brain. Further, we found that GMF and ApoE4 were strongly expressed and co-associated in APs and in the reactive astrocytes surrounding APs in AD. An increased expression of GMF in APs and neurofibrillary tangles in the AD brain, and the co-localization of GMF and ApoE4 in APs suggest that GMF and ApoE4 together should be contributing to the neuropathological changes associated with AD.

Entities:  

Keywords:  Alzheimer’s disease; amyloid plaques; apolipoprotein E4; neurofibrillary tangles; neuroinflammation

Mesh:

Substances:

Year:  2018        PMID: 29172001      PMCID: PMC5770144          DOI: 10.3233/JAD-170777

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  32 in total

Review 1.  Microglia biology in health and disease.

Authors:  Gwenn A Garden; Thomas Möller
Journal:  J Neuroimmune Pharmacol       Date:  2006-03-25       Impact factor: 4.147

Review 2.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 3.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

4.  ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion.

Authors:  Yu-Wen Alvin Huang; Bo Zhou; Marius Wernig; Thomas C Südhof
Journal:  Cell       Date:  2017-01-19       Impact factor: 41.582

5.  Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.

Authors:  T Wisniewski; A Golabek; E Matsubara; J Ghiso; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

6.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Authors:  W J Strittmatter; K H Weisgraber; D Y Huang; L M Dong; G S Salvesen; M Pericak-Vance; D Schmechel; A M Saunders; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

7.  Overexpression of glia maturation factor in astrocytes leads to immune activation of microglia through secretion of granulocyte-macrophage-colony stimulating factor.

Authors:  Asgar Zaheer; Satya N Mathur; Ramon Lim
Journal:  Biochem Biophys Res Commun       Date:  2002-06-07       Impact factor: 3.575

8.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Glia maturation factor expression in hippocampus of human Alzheimer's disease.

Authors:  Deirdre Stolmeier; Ramasamy Thangavel; Poojya Anantharam; Mohammad M Khan; Duraisamy Kempuraj; Asgar Zaheer
Journal:  Neurochem Res       Date:  2013-05-03       Impact factor: 3.996

10.  Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice.

Authors:  Smita Zaheer; Ramasamy Thangavel; Yanghong Wu; Mohammad Moshahid Khan; Duraisamy Kempuraj; Asgar Zaheer
Journal:  Neurochem Res       Date:  2012-10-20       Impact factor: 3.996

View more
  16 in total

1.  Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-κB.

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Gvindhasamy Pushpavathi Selvakumar; Mohammad Ejaz Ahmed; Smita Zaheer; Sudhanshu P Raikwar; Haris Zahoor; Daniyal Saeed; Iuliia Dubova; Gema Giler; Shelby Herr; Shankar S Iyer; Asgar Zaheer
Journal:  Mol Neurobiol       Date:  2018-06-18       Impact factor: 5.590

Review 2.  Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Arshdeep S Dhaliwal; Iuliia Dubova; Shireen Mentor; Keerthivaas Premkumar; Daniyal Saeed; Haris Zahoor; Sudhanshu P Raikwar; Smita Zaheer; Shankar S Iyer; Asgar Zaheer
Journal:  Neuroscientist       Date:  2019-05-16       Impact factor: 7.519

Review 3.  Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.

Authors:  Sudhanshu P Raikwar; Nidhi S Kikkeri; Ragha Sakuru; Daniyal Saeed; Haris Zahoor; Keerthivaas Premkumar; Shireen Mentor; Ramasamy Thangavel; Iuliia Dubova; Mohammad Ejaz Ahmed; Govindhasamy P Selvakumar; Duraisamy Kempuraj; Smita Zaheer; Shankar S Iyer; Asgar Zaheer
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-23       Impact factor: 4.147

Review 4.  Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease.

Authors:  Madhumitha Katta; Blessy Aksa Mathew; Pragya Chaturvedi; Abhilash Ludhiadch; Anjana Munshi
Journal:  Neurol Sci       Date:  2022-09-06       Impact factor: 3.830

5.  Glia Maturation Factor in the Pathogenesis of Alzheimer's disease.

Authors:  Swathi Beladakere Ramaswamy; Sachin M Bhagavan; Harleen Kaur; Gema E Giler; Duraisamy Kempuraj; Ramasamy Thangavel; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Sudhanshu P Raikwar; Smita Zaheer; Shankar S Iyer; Raghav Govindarajan; Asgar Zaheer
Journal:  Open Access J Neurol Neurosurg       Date:  2019-12-17

6.  Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation.

Authors:  Duraisamy Kempuraj; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Mohammad Ejaz Ahmed; Smita Zaheer; Keerthana Kuppamma Kumar; Anudeep Yelam; Harleen Kaur; Iuliia Dubova; Sudhanshu P Raikwar; Shankar S Iyer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Immune Suppression of Glia Maturation Factor Reverses Behavioral Impairment, Attenuates Amyloid Plaque Pathology and Neuroinflammation in an Alzheimer's Disease Mouse Model.

Authors:  Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Duraisamy Kempuraj; Sudhanshu P Raikwar; Smita Zaheer; Shankar Iyer; Asgar Zaheer
Journal:  J Neuroimmune Pharmacol       Date:  2020-06-05       Impact factor: 4.147

8.  Mast Cell Activation, Neuroinflammation, and Tight Junction Protein Derangement in Acute Traumatic Brain Injury.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Sudhanshu P Raikwar; Smita A Zaheer; Shankar S Iyer; Casey Burton; Donald James; Asgar Zaheer
Journal:  Mediators Inflamm       Date:  2020-06-24       Impact factor: 4.711

9.  Real-Time Noninvasive Bioluminescence, Ultrasound and Photoacoustic Imaging in NFκB-RE-Luc Transgenic Mice Reveal Glia Maturation Factor-Mediated Immediate and Sustained Spatio-Temporal Activation of NFκB Signaling Post-Traumatic Brain Injury in a Gender-Specific Manner.

Authors:  Sudhanshu P Raikwar; Ramasamy Thangavel; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Duraisamy Kempuraj; Kristopher Wu; Osaid Khan; Kieran Bazley; Bret Bussinger; Klaudia Kukulka; Smita Zaheer; Shankar S Iyer; Raghav Govindarajan; Casey Burton; Donald James; Asgar Zaheer
Journal:  Cell Mol Neurobiol       Date:  2020-08-12       Impact factor: 5.046

Review 10.  Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?

Authors:  Sudhanshu P Raikwar; Ramasamy Thangavel; Iuliia Dubova; Mohammad Ejaz Ahmed; Pushpavathi Govindhasamy Selvakumar; Duraisamy Kempuraj; Smita Zaheer; Shankar Iyer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.